Ketamine, a drug approved for medical use in 1970 as a short-acting anesthetic, including during the Vietnam War for battlefield surgery, is still a pharmacological mystery. For a long time, scientists knew that ketamine, which is highly valued for treating severe pain and treatment-resistant depression, primarily works by blocking NMDARs, major receptors in the brain. However, this didn't fully explain why ketamine provides rapid pain and depression relief while drugs with similar actions didn't.
3D Atomic-Level Snapshots Reveal Ketamine's Binding Mechanism to Human Opioid Receptors
A study reveals that ketamine, a drug used for anesthesia and treating severe pain and depression, binds to human opioid receptors, providing insights into its rapid therapeutic effects. This research could influence medical practices in Iran, particularly in pain management and mental health treatment. Understanding ketamine's mechanisms may lead to improved healthcare strategies in the country.
👥 Key Players
📰 What Happened
A recent study has uncovered how ketamine binds to human opioid receptors, enhancing understanding of its rapid effects in treating pain and depression. This research could change medical practices regarding ketamine use.
- Ketamine has been used since 1970 as an anesthetic and for treating severe pain and depression.
- The study reveals a new mechanism of action for ketamine that could explain its rapid therapeutic effects.
💡 Why It Matters
📚 Background
Ketamine is known for its anesthetic properties and has gained attention for its rapid antidepressant effects, making it a subject of interest in modern medicine.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%